Edward Jung founded Intellectual Ventures after leaving Microsoft Corporation where he was chief architect and advisor to executive staff. At Intellectual Ventures, Mr. Jung also serves as the chief technology officer, setting strategic technology direction for the company.

During his 10 years at Microsoft, Mr. Jung managed projects relating to Web platforms, semantic web technology, intelligent operating systems, adaptive user interfaces and artificial intelligence. Jung co-founded many Microsoft teams including Windows NT, Microsoft Research, mobile and consumer products, and web services. Before joining Microsoft in February 1990, Mr. Jung ran the Deep Thought Group, working on neural network chips for learning and parallel computation. He also consulted to and wrote software for NeXT Computer, Apple Computer and its Advanced Technology Group, and the Open Software Foundation.

An avid inventor, Mr. Jung holds more than 100 patents worldwide and has more than 900 patents pending. His issued patent holdings are in a variety of areas including biomedical research instruments and neural networks as well as several fundamental patents in object technology, distributed operating systems and semantic data analysis. Mr. Jung's biomedical research work in protein structure and function has been published in several journals including the Proceedings of the National Academy of Sciences and the Journal of Biochemistry.

Currently Mr. Jung is a strategic advisor to Harvard Medical School, the Fred Hutchinson Cancer Research Center and the Institute for Systems Biology where he advises on future synergies between biology and information technology.

Mr. Jung is also personally committed to several non-profit projects involving technology and science education, and he consults to the Asia Pacific Federation, the Aspen Institute, the China Academy of Sciences, the National Academy of Sciences, the World Economic Forum and the World Health Organization.